The company remains confident in closing the pending Sinister Labs merger. In Preparation, the company has acquired Sinister CBD as a wholly owned subsidiary of IGEX.
The acquisition of Sinister CBD was paid in consideration of 400 Series B super voting shares. Thereby also rendering the Company's CEO, Leonard Armenta, as the company's majority shareholder and avoiding any increase to common shares.